Wealthcare Advisory Partners’s Chemours CC Stock Holding History

Wealthcare Advisory Partners’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,954	Closed	-$82K	–	748
2021 Q1	$82K	Buy	+2,954	New	+$78.6K	0.01%	723
2020 Q2	–	Sell	-99	Closed	-$1K	–	462
2020 Q1	$1K	Sell	99 -1	-1%	-$14	﹤0.01%	1365
2019 Q4	$2K	Buy	100 +1	+1%	+$17	﹤0.01%	1242
2019 Q3	$1K	Sell	99 -69	-41%	-$1.12K	﹤0.01%	1270
2019 Q2	$4K	Buy	168 +1	+0.6%	+$29	﹤0.01%	1087
2019 Q1	$6K	Buy	167 +1	+0.6%	+$36	﹤0.01%	912
2018 Q4	$5K	Buy	166 +1	+0.6%	+$32	﹤0.01%	920
2018 Q3	$7K	Hold	165	–	–	﹤0.01%	923
2018 Q2	$7K	Buy	165 +86	+109%	+$4.28K	﹤0.01%	915
2018 Q1	$4K	Hold	79	–	–	﹤0.01%	856
2017 Q4	$4K	Buy	79 +9	+13%	+$471	﹤0.01%	809
2017 Q3	$4K	Buy	+70	New	+$3.3K	﹤0.01%	671

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wealthcare Advisory Partners's CC Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Chemours (CC) in Q2 2021, closing a stake of 2,954 shares — an estimated $82K sold.

Wealthcare Advisory Partners first reported a position in CC in Q3 2017 and held it in 12 quarters. The position peaked at $82K in Q1 2021. 449 funds tracked by Wall St. Rank hold CC as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Chemours position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 2,954 Chemours shares in Q2 2021, an estimated $82K.
Wealthcare Advisory Partners first reported a position in Chemours in Q3 2017 and held it in 12 quarters.
Wealthcare Advisory Partners's Chemours position peaked at $82K in Q1 2021.
449 funds tracked by Wall St. Rank held Chemours as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.